Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral BIDIME Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115490730B reveals a high-yield method for chiral BIDIME selenium/sulfur ligands, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115490730A reveals a novel synthesis for chiral BIDIME Se/S ligands using modified diatomite purification, offering high yields and scalable production for pharmaceutical intermediates.